Evidence map›Paper›PMID 33894187›Full record

ArticleThe Lancet. Neurology2021

The International Parkinson Disease Genomics Consortium Africa.

Mie Rizig, Njideka Okubadejo, Mohamed Salama, Omotola Thomas, Albert Akpalu, Riadh Gouider, IPDGC Africa

Abstract readLetter
In one paragraph

Article in The Lancet. Neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Underrepresented Populations in Parkinson's Genetics Research: Current Landscape and Future Directions.Movement disorders : official journal of the Movement Disorder Society · 2022
    Pooled it
  2. Review
  3. Review
  4. Early-Onset Parkinson's Disease: Unique Features and Management Approaches.Current neurology and neuroscience reports · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. medRxiv : the preprint server for health sciences · 2023
    Article
  13. Review
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mie RizigUCL Queen Square Institute of Neurology, London WC1N 3BG, UK. Electronic address: m.rizig@ucl.ac.uk.
Njideka OkubadejoNeurology Unit, Department of Medicine, College of Medicine, University of Lagos, Lagos, Nigeria.
Mohamed SalamaInstitute of Global Health and Human Ecology, American University in Cairo, Cairo, Egypt.
Omotola ThomasParkinson's Africa, London, UK.
Albert AkpaluDepartment of Medicine, University of Ghana Medical School, Accra, Ghana.
Riadh GouiderDepartment of Neurology, Clinical Investigation Center of Neurosciences and Mental Health, Razi University Hospital, Tunis, Tunisia; Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
IPDGC Africa

Funding

Genome wide SNP analysis in Parkinson's diseaseZ01AG000949 · NIA · NATIONAL INSTITUTE ON AGING · PI SINGLETON, ANDREW B · 2006 to 2008
$2.6M
Intramural NIH HHS Z01 AG000949
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

GenomicsInternational CooperationAfricaHumansParkinson DiseaseRegistries

Identifiers

PMID33894187
PMCPMC8941488

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.